Linkedin Facebook Instagram X-twitter
  • XCHG: SYMB
  • XCHG: SYMB
  • XCHG: SYMB
Main Menu
PRESENTATION
SUBSCRIBE
MENU

OUR TECH

Risk Screening is Critical

ALZAI technology is designed to enable early detection of patients with Alzheimer’s disease and at high-risk of developing disease, creating critical opportunities:

  • To make a substantial difference in patient trajectories and outcomes.
  • To avoid many cases of disease through preventative interventions.
  • To make the clinical workflow more cost-effective for payors
  • To enable more efficient clinical trials for needed Alzheimer’s drugs
  • To help patients make informed decisions about medical, financial and legal matters

The Problem

Early-Stage Alzheimer’s Disease remains widely undiagnosed due to the absence of risk screening, delaying intervention and treatment. Screening today relies on physician suspicion. Without systematic, automated, and sensitive risk assessment, early intervention is rare, diagnosis is delayed, treatment is compromised, leading to patients suffering more and the system paying more.

Only 17%

Mild AD/MCI* cases identified. 1

*AD: Alzheimer’s Disease  MCI: Mild Cognitive Impairment

1. Alzheimer’s Association

The Solution

Using only common existing data from the Electronic Medical Records (EMR), ALZAI automatically processes that data through a sequence of proprietary AI algorithms adhering to patient data security. ALZAI can integrate directly into patient data systems or connect through the cloud to seamlessly screen populations,​ identifying high-risk patients. By providing valuable clinical decision support for physicians, ALZAI enables earlier diagnosis and treatment for the ill, and preventative care for the at-risk.​

80%

Mild AD/MCI* cases identified.

*AD: Alzheimer’s Disease  MCI: Mild Cognitive Impairment

ALZAI Risk Assessment:
A Seamless Screening Experience

Our platform offers an intuitive, easily integrated solution for healthcare providers, clinical researchers, and stakeholders. It seamlessly integrates with Electronic Medical Record (EMR) systems, delivering risk screening results stratified by year and quantified by confidence level.